| Autor: |
Zhou, Xiang, Bai, Tao, Meckel, Katharina, Song, Jun, Jin, Yu, Kortüm, K. Martin, Einsele, Hermann, Hou, Xiaohua, Rasche, Leo |
| Předmět: |
|
| Zdroj: |
Annals of Hematology; Mar2021, Vol. 100 Issue 3, p843-846, 4p |
| Abstrakt: |
Copyright comment corrected publication 2021 Dear Editor, The Chinese colleagues from Wuhan reported for the first time the novel coronavirus (COVID-19), which caused severe acute respiratory syndrome [[1]]. The patient No. 7 who was receiving the frontline therapy with VTD also had an elevated procalcitonin value (30.05 ng/ml), suggesting an additional bacterial infection, and, despite maximal medical care, this patient died due to acute respiratory failure. Importantly, MM patients with COVID-19 infection need close monitoring for severe COVID-19-related complications, and early intervention may be life-saving for the patients [[11]]. [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Full text from SpringerLink